Division of Abbott Laboratories Inc.
Latest From Health Net
Boston Scientific reported disappointing first-quarter results for its cardiac rhythm management division, mostly due to price erosion in the U.S and the lack of a quadripolar CRT-D device. But the firm argues that the new S-ICD and forthcoming quadripolar CRT-D products may help turn the business around soon.
Drugs for hepatitis C have historically been subject to prior authorization requirements, mainly to confirm that the patient is infected and to align treatment duration with a patient’s viral load. However, Health Net’s criteria goes further toward limiting the number of patients who get coverage.
With the acquisition, CVS Caremark would add approximately 400,000 members to its stand-alone Medicare prescription drug plan business, solidifying its position as number two in the PDP market.
- Therapeutic Areas
- Cardiovascular > Arteriosclerosis-Atherosclerosis
- North America
- Parent & Subsidiaries
- Abbott Laboratories Inc.
- Senior Management
Andrea Tiller, CFO
Rita Duarte, EVP
Michael Siegel, MD, CMO
- Contact Info
Phone: (818) 719-6703
21600 Oxnard Street
Woodland Hills, CA 91367-
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.